Jobst Technologies got granted the new H2020 Key Enabling Technologies project 737212 – CATCH-U-DNA.

Seven partners aim to enable analysis for free circulating tumor DNA – a major brick in individualized cancer treatment. This project will strengthen Jobst’s vanguard position in performance micro-fluidics and extreme bio-sensing.